期刊文献+

高效抗逆转录病毒疗法治疗24周AIDS患者Th17和Treg细胞的表达特点 被引量:3

Expression characteristics of Th17 and Treg cells in AIDS patients with 24 weeks highly active antiretroviral treatment
下载PDF
导出
摘要 目的:观察高效抗逆转录病毒疗法(HAART)治疗24周后获得性免疫缺陷综合征(AIDS)患者辅助性17(Th17)细胞和调节性T(Treg)细胞表达水平的变化。方法选取HAART治疗的45例AIDS患者,将其按CD4+T细胞计数分成1~100 cells/μl、101~200 cells/μl和201~350 cells/μl三组,于抗病毒前和抗病毒24周后采集静脉血,运用流式细胞仪检测外周血中CD4+T细胞、Th17和Treg细胞的表达水平,并比较分析其相互关系。结果 AIDS患者治疗24周时Th17细胞在CD4+T细胞中的表达频率为(1.91±0.84)%,而治疗前为(1.31±0.45)%,差异有统计学意义(t=3.67, P<0.05); Treg细胞表达频率在治疗24周时和治疗前分别为(5.97±0.93)%和(8.32±1.12)%,差异有统计学意义(t=3.32,P<0.05)。治疗24周时,Th17细胞明显升高,CD4+T细胞基数为201~350 cells/μl患者组其Th17细胞表达频率显著高于101~200 cells/μl和1~100 cells/μl组患者(t分别=2.68、4.51,P均<0.05)。 Treg细胞表达频率经治疗后显著下降,CD4+T细胞基数为201~350 cells/μl组患者Treg细胞表达频率下调程度显著高于101~200 cells/μl和1~100 cells/μl组患者(t分别=2.47、3.89,P均<0.05)。治疗前CD4+T细胞数与Th17表达的百分率呈正相关(r=0.48, P<0.05),与Treg表达的百分率呈负相关(r=-0.30,P<0.05)。结论 AIDS患者Th17表达水平下降,Treg表达则上升;HAART治疗能有效地上调Th17表达频率,下调Treg细胞水平;CD4+T细胞基数高的患者较基数低的患者对抗病毒治疗其免疫反应更有效,提示Th17和Treg细胞表达频率可作为HAART治疗有效性的一项判断依据。 Objective To observe the expression levels of Th17 and Treg cells of acquired immune deficiency syn-drome(AIDS) suffered patients after 24 weeks highly active antiretroviral treatment(HAART). Methods According to the CD4+T cell amounts , 45 AIDS patients received HAART treatment were divided into three groups. Flow cytometry technol-ogy was used to detect the CD4+T Cells count, Treg and Th17 cells in peripheral blood at the time of pre-therapy and 24 weeks. Results The ratio of Th17 cells in AIDS patients was (1.91±0.84)%in 24 weeks, and was (1.31±0.45)% at the time of pre-therapy, the difference was significant(t=3.67, P〈0.05). The expression level of Treg was (5.97±0.93)%and (8.32±1.12) % at the time of 24 weeks treatment and pre-therapy with statistical significance (t=3.32,P〈0.05). Th17 cells expression level was raised after 24 weeks, and which of CD4+T cells for 201~350 cells/μl group showed a remarkable decline than those of CD4+T cells for 101~200 cells/μl and 1~100 cells/μl groups (t=2.68,4.51,P〈0.05).Treg cells ex-pression level were down-regulated after 24 weeks treatment, and the dropped levels with of CD4+ T cells for 201~350cells/μl group was higher than those of two other groups(t=2.47,3.89,P〈0.05). Th17 cells was significantly positively related to the percentage of CD4+T cells count(r=0.48, P〈0.05);the correlation of Treg expression and CD4+T Cells count was significantly negative(r=-0.30, P〈0.05) at the time of pre-therapy. Conclusions The expression level of Th17 cells decreased,while Treg cells was increased in AIDS patients; HAART treatment could upregulated Th17 cells level and downregulated Treg cells. The patients with higher baseline of CD4+T cells has higher immune reaction effective than that of the lower baseline CD4+T cells. The Th17 and Treg cells are likely to be the effective indexes to observe HAART progress.
出处 《全科医学临床与教育》 2014年第1期26-29,共4页 Clinical Education of General Practice
基金 绍兴市重点科技计划项目(2011A23016)
关键词 TH17细胞 TREG细胞 获得性免疫缺陷综合征 高效抗逆转录病毒治疗 Th17 cells Treg cells acquired immune deficiency syndrome highly active antiretroviral treatment
  • 相关文献

参考文献6

  • 1Li D,Chen J,Jia M. Loss of balance between T hepler type 17 and regulatory T cell in chronic human immunode-ficiency virus infection[J].Cli Exp Immunol,2011,(03):363-371.
  • 2Yan H,Jing L,Yuhuang Z. A Randomized case-control study of Dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active an-tiretroviral-treated HIV type 1/AIDS patients[J].{H}AIDS Research and Human Retroviruses,2012,(04):339-345.
  • 3Zaba LC,Fuentes-Duculan J,Eungdamrong NJ. Pso-riasis is characterized by accumulation of mmunostimulatory and Thl/Thl7 cell-polarizing myeloid dendritic cells[J].J In-vest Dermatol,2009,(01):79-88.
  • 4Stoc Kinger B,Veldhoen M. Differentiation and function of Th17 T cells[J].{H}CURRENT OPINION IN IMMUNOLOGY,2007,(03):281-286.
  • 5Marhaba R,Vitacolonna M,Hildebrand D. The impor-tance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema[J].{H}Journal of Immunology,2010,(10):5071-5081.
  • 6李靖,何艳,郑煜煌,周华英,谌资,陈霞,罗艳,姚运海,贺梅.湖南艾滋病患者Th17和Tr细胞及IL-17在抗病毒治疗过程中的变化[J].中华微生物学和免疫学杂志,2011,31(6):512-516. 被引量:5

二级参考文献17

  • 1Marhaba R, Vitacolonna M, Hildebrand D, et al. The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J Immunol, 2007, 179(8) : 5071-5081.
  • 2Yin B, Ma G, Yen CY, et al. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol, 2010, 185 (10) : 5828-5834.
  • 3Zhou Z, French DL, Ma G, et al. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Ceils, 2010, 28 (3) : 620-632.
  • 4Ilkovitch D, Lopez DM. The liver is a site for tumor-induced mye- loid-derived suppressor cell accumulation and immunosuppression. Cancer Res, 2009, 69(13): 5514-5521.
  • 5Zhu B, Bando Y, Xiao S, et al. CDllb+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Im- munol, 2007, 179(8) : 5228-5237.
  • 6Kerr EC, Raveney BJ, Copland DA, et al. Analysis of retinal eel- lular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J Autoimmun, 2008, 31 (4) : 354-361.
  • 7Halle LA, yon Wasielewski R, Gamrekelashvili J, et al. Myeloid- derived suppressor cells in inflammatory bowel disease: a new im- munoregulatory pathway. Gastroenterology, 2008, 135 (3) : 871-881, 881. el-5.
  • 8Highfill SL, Rodriguez PC, Zhou Q, et al. Bone marrow myeloid- derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-l-dependent mechanism that is up-regu- lated by interleukin-13. Blood, 2010, 116(25) : 5738-5747.
  • 9Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 2009, 9(3) : 162-174.
  • 10Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol, 2008, 181 (8) : 5791-5802.

共引文献4

同被引文献24

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部